B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab

R. John Looney, Jennifer H. Anolik, Debbie Campbell, Raymond E. Felgar, Faith Young, Lois J. Arend, James A. Sloand, Joseph Rosenblatt, Iñaki Sanz

Research output: Contribution to journalArticlepeer-review

659 Scopus citations

Fingerprint Dive into the research topics of 'B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab'. Together they form a unique fingerprint.

Medicine & Life Sciences